Abstract:AIM:To look for new heart or kidney imaging agents. Five new target chelators--2-N-(2'-s-triphenylmethylacetyl) amino-(N'-acetyl glycine) isovalericamide (MVG2), 2-N-(2'-s-triphenylmethylacetyl) amino-[N'-acetyl-(N"-butylacetaminde)] isovalericamide (MVGT), 2-N-(2'-s-tri-phenylmethylacetyl) amino-[N'-acetyl-(N"-cyclohexanylacetaminde)] isovalericamide (MVGH), 2-N-(2'-s-triphenylmethylacetyl) amino-[N'-acetyl-(N"-butylacetaminde)] phenyl propamide (MPGT) and 2-N-(2'-s-triphenylmethylacetyl) amino-[N'-acetyl-(N"-cyclohexanylacetaminde)] phenylpropamide (MPGH) were synthesized as primitive materials to explore the synthetic methods of polypeptides.METHODS AND RESULTS:All target chelators were identified on the basis of the spectroscopic data, such as IR, 1HNMR, 13CNMR and elementary analysis. Different active esters with mercaptoacetic acid as primitive materials were used to explore the biodistribution of Technetium-99m labelling chelators in mice. The chelators were labeled with Technetium-99m and further tested for the biological activity in mice. Values given in ID which is the percentage injected dose per organ was tested to explore new heart imaging agents. The ID was determined in vivo by biodistribution study. Tc-99m complexes 0.1 mL was injected into laterial tail vein of 3 anaesthetised rats. At 2, 5, 10, 30, 60 minutes post-injection, rats were sacrificed by decapitation, bled from the neck and the organs were removed. The radioactivities in various organs were determined in an automatic twin crystal gamma counter. Five new target chelators were labeled with Technetium-99m in high yield (> 95%). The bio-distribution resulted in mice indicate that 99Tcm-MVG2 has high kidney uptake, good retention, quick blood clearance and high activity ratios of kidneys to other tissues. 99Tcm-MVGT, 99Tcm-MVGH and 99Tcm-MPGT have better heart accumulation, but shorter retention, slower blood clearance and lower activity ratios of kidneys to other tissues. They were mainly metabolized through liver and kidney.CONCLUSION:99Tcm-MVG2 will be a new potential renal function imaging agent and 99Tcm-MVGT, 99Tcm-MVGH and 99Tcm-MPGT will be new potential heart function imaging agents if their structure and activity relationships are further studied.

Technetium-99m Labeling on Monoclonal Antibodies Via N,N'-Ethylene-Bis-L-Cysteine

Direct Technetium-99m Labeling of Anti-Hepatoma Monoclonal Antibody Fragment: A Radioimmunoconjugate for Hepatocellular Carcinoma Imaging

A NEW BIFUNCTIONAL CHELATING AGENT Α,ε-N,n'-bis(l-cysteinyl)-l-lysine FOR RADIOLABELLING OF MONOCLONAL ANTIBODIES WITH TECHNETIUM-99M

Studies of 99mTc labeled carcinoembyronic antigen monoclonal antibody C50 fragment Fab' and biodistrobution

99Mtc-Labeled HAb18 McAb Fab Fragment for Radioimmunoimaging in Nude Mice Bearing Human Hepatocellular Carcinoma.

A Study of 99tcm Labelling of Monoclonal Antibody 2F7 F (ab′)2 Segment Against Small Cell Lung Cancer

Methods for MAG3 Conjugation and 99mtc Radiolabeling of Biomolecules

Labeling Monoclonal-Antibodies with Yttrium-90-Dota and Indium-111-Dota Chelates - A Simple and Efficient Method

An Efficient Method for the Site-Specific 99m Tc Labeling of Nanobody

Experimental Study of the Biological Property and Safety Limitation of 99Mtc-C50

Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy

Synthesis of Labelled Small Peptide Complexes for Imaging Agents with Technetium-99M and Biodistribution in Mice.

Synthesis and Preliminary Biological Evaluation of a Technetium-99M Labeled Thymidine Analog

Preparation and Biological Evaluation of a Technetium-99M Labeled 4-Nitroimidazole Derivative for Imaging Tumor Hypoxia

Synthesis and characterization of novel N3S chelators and biodistribution of their 99Tcm labeled complexes as potential kidney imaging agents

Pharmacokinetics of technetium-99m labeled anti-hepatoma monoclonal antibody HAb18 and it's F(ab')2 fragment in mice

Tumor Imaging by a 99m TcO 4 - -Labeled Cationic Polymeric Network

Quantitative 99m Tc Labeling Kit for HYNIC-Conjugated Single Chain Antibody Fragments Targeting Malignant Mesothelioma

New Peptide Labeling Technique Based on Bifunctional Reagent and Rare Earth Metal Chelating Tags

99m Tc-labeled colchicine for tumor imaging using DTPA as bifunctional chelating agent

An Improved Synthesis Of Nhs-Mag3 For Conjugation And Radiolabeling Of Biomolecules With Tc-99m At Room Temperature